Abstract | OBJECTIVE: To compare the clinical efficacy and systemic side effects of2.5% and 10%phenylephrinefor mydriasis in diabetic patient with darkly pigmented irides. MATERIAL AND METHOD: A prospective randomized double-blind controlled trial was conducted. One hundred diabetic patients were randomly allocated into 2.5% and 10% phenylephrine groups by block randomization. Pupil diameter, blood pressure and heart rate were measured before and after eye drop instillations. RESULTS: The mean pupil diameters after instillation in the right eye were 7.05 +/- 0.71 mm (2.5% phenylephrine group) and 7.40 +/- 0.72 mm (10% phenylephrine group, p = 0.02) and in the left eye were 7.05 +/- 0.72 mm (2.5% phenylephrine group) and 7.39 +/- 0.72 mm (10% phenylephrine group, p = 0.02). There was no clinically significant difference in mean heart rate, mean systolic and diastolic blood pressure. CONCLUSION: In diabetic patients with darkly pigmented irides, 10% phenylephrine is more effective than 2.5% phenylephrine with statistical significance. The authors recommend a single dose of 10% phenyleprine for mydriasis in these patients. However the lower concentration is recommended for use in those who exhibit a higher prevalence ofsignificant vascular disease and autonomic dysfunction and seem to be susceptible to severe adverse reaction of phenylephrine.
|
Authors | Olan Suwan-Apichon, Tanapat Ratanapakorn, Ronakorn Panjaphongse, Suthasinee Sinawat, Thuss Sanguansak, Yosanan Yospaiboon |
Journal | Journal of the Medical Association of Thailand = Chotmaihet thangphaet
(J Med Assoc Thai)
Vol. 93
Issue 4
Pg. 467-73
(Apr 2010)
ISSN: 0125-2208 [Print] Thailand |
PMID | 20462091
(Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Mydriatics
- Ophthalmic Solutions
- Phenylephrine
|
Topics |
- Adult
- Aged
- Cohort Studies
- Diabetic Retinopathy
(complications, drug therapy, pathology)
- Double-Blind Method
- Eye Color
- Female
- Humans
- Male
- Middle Aged
- Mydriasis
(drug therapy, etiology, pathology)
- Mydriatics
(administration & dosage)
- Ophthalmic Solutions
- Phenylephrine
(administration & dosage)
- Treatment Outcome
- Young Adult
|